Literature DB >> 16186923

Synthesis, characterisation and theoretical calculations of 2,6-diaminopurine etheno derivatives.

Piritta Virta1, Andreas Koch, Mattias U Roslund, Peter Mattjus, Erich Kleinpeter, Leif Kronberg, Rainer Sjöholm, Karel D Klika.   

Abstract

Four derivatives of 2,6-diaminopurine (1) were synthesised and characterised. When 1 was reacted with chloroacetaldehyde, 5-aminoimidazo[2,1-i]purine (2), 9-aminoimidazo[2,1-b]purine (3), 9-aminoimidazo[1,2-a]purine (4) and diimidazo[2,1-b:2',1'-i]purine (5) were formed. The purified products (3-5) were fully characterised by MS, complete NMR assignments as well as fluorescence and UV spectroscopy. The purified, isolated yields of these products (3-5) varied from 2.5 to 30%. The relative stability of different tautomers was investigated by theoretical calculations. Fluorescence characteristics are also discussed and compared to the starting material 1 and a reference molecule 2-aminopurine.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16186923     DOI: 10.1039/b505508c

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  3 in total

1.  Formation of 5-Hydroxy-3-methoxy-1,4-naphthoquinone and 8-Hydroxy-4-methoxy-1,2-naphthoquinone from Juglone.

Authors:  Bastian Blauenburg; Mikko Metsä-Ketelä; Karel D Klika
Journal:  ISRN Org Chem       Date:  2012-09-23

2.  Impact of Linker Modification and PEGylation of Vancomycin Conjugates on Structure-Activity Relationships and Pharmacokinetics.

Authors:  Florian Umstätter; Julia Werner; Leah Zerlin; Eric Mühlberg; Christian Kleist; Karel D Klika; Tobias Hertlein; Barbro Beijer; Cornelius Domhan; Stefan Zimmermann; Knut Ohlsen; Uwe Haberkorn; Walter Mier; Philipp Uhl
Journal:  Pharmaceuticals (Basel)       Date:  2022-01-28

3.  Direct measurement of the ionization state of an essential guanine in the hairpin ribozyme.

Authors:  Lu Liu; Joseph W Cottrell; Lincoln G Scott; Martha J Fedor
Journal:  Nat Chem Biol       Date:  2009-03-29       Impact factor: 15.040

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.